129 related articles for article (PubMed ID: 6889921)
1. Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas.
von Heyden HW; Scherpe A; Nagel GA
Cancer Treat Rev; 1982 Jun; 9 Suppl():45-52. PubMed ID: 6889921
[No Abstract] [Full Text] [Related]
2. Etoposide as single agent and in combination with cis-platinum for malignant lymphomas.
Kroner T; Obrecht JP; Jungi WF
Cancer Treat Rev; 1982 Jun; 9 Suppl():39-43. PubMed ID: 6889920
[No Abstract] [Full Text] [Related]
3. Cis-dichlorodiammineplatinum (II), VP 16-213, and prednisone (DVP regimen) in the treatment of pretreated advanced malignant lymphomas.
Fosser VP; Salvagno L; Segati R; Pappagallo GL; Ferrazzi E; Sileni VC; Fiorentino MV
Tumori; 1982 Dec; 68(6):515-8. PubMed ID: 6762740
[TBL] [Abstract][Full Text] [Related]
4. Combination cis-platinum and etoposide in small-cell lung cancer.
Natale RB; Wittes RE
Cancer Treat Rev; 1982 Jun; 9 Suppl():91-4. PubMed ID: 6290058
[No Abstract] [Full Text] [Related]
5. Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinum.
Mitrou PS; Fischer M; Weissenfels I; Diehl V; Gropp C; Liesenfeld A; Schmidt M; Berdel WE; Fink U; Graubner M
Cancer Treat Rev; 1982 Jun; 9 Suppl():139-42. PubMed ID: 6889919
[No Abstract] [Full Text] [Related]
6. Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.
Klastersky J; Longeval E; Nicaise C; Weerts D
Cancer Treat Rev; 1982 Jun; 9 Suppl():133-8. PubMed ID: 6889918
[No Abstract] [Full Text] [Related]
7. Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
Athanassiades P; Bacoyiannes H; Kontoyiannes D
Chemioterapia; 1986 Apr; 5(2):125-7. PubMed ID: 3518965
[TBL] [Abstract][Full Text] [Related]
8. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.
Sierocki JS; Hilaris BS; Hopfan S; Martini N; Barton D; Golbey RB; Wittes RE
Cancer Treat Rep; 1979; 63(9-10):1593-7. PubMed ID: 227598
[TBL] [Abstract][Full Text] [Related]
9. Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancer.
Goldhirsch A; Joss RA; Cavalli F; Sonntag RW; Brunner KW
Med Pediatr Oncol; 1981; 9(3):205-8. PubMed ID: 6264280
[TBL] [Abstract][Full Text] [Related]
10. Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
Creagan ET; Eagan RT; Kvols LK
Oncology; 1981; 38(5):260-1. PubMed ID: 7196561
[TBL] [Abstract][Full Text] [Related]
11. Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
Gutierrez ML; Crooke ST
Cancer Treat Rev; 1979 Sep; 6(3):153-64. PubMed ID: 394834
[No Abstract] [Full Text] [Related]
12. VP16-213 combined with cis-platinum (CDDP) in the treatment of small cell carcinoma of the lung (SCLC).
Madrigal PA; Manga GP; Palomero I; Gomez RG
Cancer Chemother Pharmacol; 1982; 7(2-3):203-4. PubMed ID: 6282485
[No Abstract] [Full Text] [Related]
13. [Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].
Konishi I; Kitani T; Nagai K; Kanamaru A; Kohsaki M; Masaoka T; Shibata H; Horiuchi A; Tsubaki K; Kawagoe H
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1482-6. PubMed ID: 4015122
[TBL] [Abstract][Full Text] [Related]
14. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
Eagan RT
Cancer Treat Rev; 1982 Jun; 9 Suppl():119-31. PubMed ID: 6889917
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Havemann K
Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
[No Abstract] [Full Text] [Related]
16. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
[TBL] [Abstract][Full Text] [Related]
17. MACC (methotrexate, doxorubicin, cyclophosphamide and lomustine) versus cis-platinum and etoposide in the treatment of advanced non-small cell lung cancer.
Buccheri G; Ferrigno D; Curcio A; Vola F; Mattalia E
Chemioterapia; 1986 Feb; 5(1):53-7. PubMed ID: 3955784
[TBL] [Abstract][Full Text] [Related]
18. Etoposide as a single agent in relapsed advanced lymphomas. A phase II study.
Taylor RE; McElwain TJ; Barrett A; Peckham MJ
Cancer Chemother Pharmacol; 1982; 7(2-3):175-7. PubMed ID: 7083459
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of VP-16-213 in advanced ovarian carcinoma.
Hillcoat BL; Campbell JJ; Pepperell R; Quinn MA; Bishop JF; Day A
Gynecol Oncol; 1985 Oct; 22(2):162-6. PubMed ID: 4054715
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
